Terveystalo Oyj header image

Terveystalo Oyj

TTALO

Equity

ISIN FI4000252127 / Valor 37893402

NASDAQ Helsinki Ltd, Equities (2026-09-04)
EUR 7.93+1.28%

Terveystalo Oyj
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Terveystalo Oyj stands as Finland's premier private healthcare service provider, distinguished by its extensive revenue and expansive network. It holds a significant position in the Nordic region as a foremost provider of occupational health services. The company's comprehensive offerings encompass a broad spectrum of primary healthcare, specialized care, and well-being services catering to a diverse clientele that includes corporate entities, private individuals, and the public sector. Terveystalo's innovative approach is further exemplified by its round-the-clock digital services, ensuring healthcare accessibility irrespective of geographical and temporal constraints. With a robust presence manifested through over 377 clinics across Finland and 152 occupational health service clinics in Sweden, Terveystalo demonstrates a commitment to healthcare excellence. The company's notable market position is underscored by its listing on the Helsinki Stock Exchange and its recognition as an attractive employer within the healthcare and pharmaceutical industry. In 2023, Terveystalo reported a revenue of EUR 1,286 million, serving approximately 1.2 million individual customers in Finland through around 7.6 million customer appointments. The organization's workforce comprises over 15,500 healthcare and well-being professionals, highlighting its substantial contribution to the healthcare sector. Additionally, Terveystalo's engagement in clinical research, through its Terveystalo Biobank and Clinical Research (TBCR) unit, emphasizes its role in advancing medical knowledge and practices.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-24.0%1Y
0.63%3Y
-36.6%5Y

Performance

24.8%1Y
26.7%3Y
27.1%5Y

Volatility

Market cap

1168 M

Market cap (USD)

Daily traded volume (Shares)

179,296

Daily traded volume (Shares)

1 day high/low

10.48 / 10.34

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 102.92
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.21%CHF 57.30
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%GBP 120.06
Aurora Cannabis Inc
Aurora Cannabis Inc Aurora Cannabis Inc Valor: 132838450
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.49%CAD 5.45
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.13%USD 86.35
Neumora Therapeutics Inc
Neumora Therapeutics Inc Neumora Therapeutics Inc Valor: 129329732
star